ACETAMINOPHEN
-
acetaminophen tablet, film coated, extended release
Medline Industries, Inc.
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Taking the blood thinning drug warfarin.
These could be signs of a serious condition.
Ask a health professional before use.
Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
adults |
▪ take 2 caplets every 8 hours with water ▪ swallow whole - do not crush, chew, split or dissolve ▪ do not take more than 6 caplets in 24 hours ▪ do not use for more than 10 days unless directed by a doctor |
under 18 years of age | ▪ ask a doctor |
Croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, propylene glycol, sodium lauryl sulfate, stearic acid, titanium dioxide
†Compare to the Active Ingredient in Tylenol®Arthritis Pain
ACETAMINOPHEN EXTENDED-RELEASE TABLETS, USP 650 mg
For the Temporary Relief of Minor Arthritis Pain
*50 CAPLETS - 650 mg EACH (*capsule-shaped tablets)
Distributed by: Medline Industries, Inc.
ACETAMINOPHEN
acetaminophen tablet, film coated, extended release | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA076200 | 04/30/2002 |
Labeler - Medline Industries, Inc. (025460908) |
Registrant - Ranbaxy Pharmaceuticals Inc. (937890044) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Ohm Laboratories Inc. | 184769029 | manufacture |